Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer

British Journal of Cancer

Volumn 85, Issue 3, 2001, Pages 393-397

  Sidiropoulos, M ^a   Chang, A ^a,b   Jung, K ^c   Diamandis, E P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Androgen regulated transcript; Differentially expressed genes; PART 1; Prostate cancer; Quantitative RT PCR; Tumour markers

Indexed keywords

ESTROGEN DERIVATIVE; GLUCOCORTICOID; PROGESTERONE DERIVATIVE; PROSTATE ANDROGEN REGULATED TRANSCRIPT 1; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

AGED; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 0035800449     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1883     Document Type: Article

References (15)

1. The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast
2. Prostate-specific antigen: A cancer fighter and a valuable messenger?
3. Human glandular kallikreins 2: A potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer
4. PART-1: A novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12
5. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA
6. Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue
7. Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era
8. Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997
9. Factors influencing use of the prostate-specific antigen screening test in primary care
10. Prostate-specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate
11. Molecular and genetic mechanisms of prostate cancer
12. Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): Two closely related, but distinct, kallikreins in the prostate
13. The androgen receptor in LNCaP cell lines contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens
14. Urological cancers: Do early detection strategies exist?